<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02959190</url>
  </required_header>
  <id_info>
    <org_study_id>16108</org_study_id>
    <secondary_id>I5Q-JE-CGAP</secondary_id>
    <nct_id>NCT02959190</nct_id>
  </id_info>
  <brief_title>A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine</brief_title>
  <official_title>A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 (Galcanezumab) in Japanese Patients With Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to evaluate the safety and effectiveness of the study drug&#xD;
      known as Galcanezumab in Japanese participants with migraine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2017</start_date>
  <completion_date type="Actual">August 10, 2019</completion_date>
  <primary_completion_date type="Actual">August 10, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Had Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>Up To 16 Months</time_frame>
    <description>A TEAE started on or after the date and time of the first dose of study drug administered in this study, or started prior to the study drug administration but worsened after the study drug started. Clinically significant events were defined as SAEs and other non-serious adverse events (AEs). A summary of SAEs and other non-serious AEs is located in the Reported Adverse Events module.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetics (PK): Serum Concentration of Galcanezumab</measure>
    <time_frame>Month 12: Predose</time_frame>
    <description>Serum Concentration of Galcanezumab at month 12 is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacodynamics (PD): Plasma Concentration of Total Calcitonin Gene-Related Peptide (CGRP)</measure>
    <time_frame>Month 12: Predose</time_frame>
    <description>Plasma Concentration of total CGRP at month 12 is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Developing Anti-Drug Antibodies (ADA)</measure>
    <time_frame>Month 0, 1, 2, 3, 6, 9, 12 and 16: Predose; Month 0 and 14 days Postdose</time_frame>
    <description>Treatment emergent ADA will be defined as any of the following:&#xD;
A negative baseline result and a positive post-baseline ADA result with a titer ≥20. This is also called treatment-induced ADA.&#xD;
A positive baseline result and a positive post-baseline ADA result with a ≥4-fold increase in titers (for example, baseline titer of 10 increasing to ≥40 post-baseline). This is called treatment-boosted ADA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Baseline in the Number of Migraine Headache Days (MHDs)</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Migraine Headache Day (MHD):A calendar day on which a migraine headache or probable migraine headache occurred.&#xD;
Migraine Headache (EM Participants): A headache, with or without aura, of ≥30 minutes duration with both of the following required features (A and B): A) At least 2 of the following headache characteristics: Unilateral location; Pulsatile quality; Moderate or severe pain intensity; Aggravation by or causing avoidance of routine physical activity; AND B) During headache at least one of the following: Nausea and/or vomiting; Photophobia and phonophobia.&#xD;
Migraine Headache (CM Participants) : A headache, with or without aura, of greater than or equal to (≥30) minutes duration which meets criteria A and B or meets criterion C: A and B criteria as described above and criteria C) The headache is believed by the participant to be migraine at onset and is relieved by a triptan or ergot derivative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Baseline in the Number of Headache Days (HDs)</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>A headache day is calendar day on which any type of headache occurs,(including migraine headache, probable migraine headache, and non-migraine headache).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Meeting Criteria for Reductions From Baseline Greater Than or Equal to (≥) 50% in Number of Migraine Headache Days</measure>
    <time_frame>Month 12</time_frame>
    <description>Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred. A 50% responder in a particular month is any participant who has a ≥50% reduction from baseline in the monthly number of migraine headache attacks in a 30-day interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Baseline in the Number of Monthly Migraine Headache Days Requiring Medication for the Acute Treatment of Migraine Headache</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Migraine Headache Day (MHD) with Acute Medication Use: Calendar days on which migraine or probable migraine occurs, requiring acute medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Change From Baseline in the Number of Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache: Calendar days on which headache, migraine or probable migraine occurs, requiring acute medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Patient Global Impression of Severity (PGI-S) Score</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>The PGI-S scale is a patient-rated instrument that measures patients own global impression of their illness severity. The patient was instructed as follows: &quot;Considering migraine as a chronic condition, how would you rate your level of illness?&quot; Response options were from 1 (&quot;normal, not at all ill&quot;) to 7 (&quot;extremely ill&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline on the Migraine Disability Assessment Test (MIDAS) Total Score</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>The MIDAS is a participant-rated scale which was designed to quantify headache-related disability over a 3-month period. This instrument consists of five items that reflect the number of days reported as missing or with reduced productivity at work or home, and the number of days of missed social events. Each item has a numeric response range from 0 to 90 days, if days are missed from work or home they are not counted as days with reduced productivity at work or home. The numeric responses are summed to produce a total score ranging from 0 to 270, in which a higher value is indicative of more disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline on the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>MSQ version 2.1 is a health status instrument,with a 4-week recall period,developed to address physical &amp; emotional limitations of specific concern to individuals with migraine.Addressing the impact of migraine on work or daily activities,relationships with family &amp; friends,leisure time,productivity,concentration, energy,tiredness &amp; feelings.It consists of 14 items addressing 3 domains:(1)Role Function-Restrictive (items 1-7);(2)Role Function- Preventive (items 8-11);&amp;(3)Emotional Function (items 12-14).Response options range from &quot;none of the time&quot; (value 1) to &quot;all of the time&quot; (value 6), &amp; are reverse-recoded (value 6 to 1) before the domain scores are calculated.Total raw scores for each domain is the sum of the final item value for all of the items in that domain.After total raw score is computed for each domain &amp; total score, they are transformed to a 0-100 scale with higher scores indicating a better health status &amp; a positive change in scores reflecting functional improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Positive Responses on Patient Satisfaction With Medication Questionnaire-Modified (PSMQ-M)</measure>
    <time_frame>Month 12</time_frame>
    <description>The PSMQ-M is a self-rated scale which measures participants level of satisfaction with study medication.The scale has been modified for use in this study, assessing 3 items related to the clinical trial treatment over the past 4 weeks: satisfaction, preference, and side effects.Satisfaction responses range from &quot;very unsatisfied&quot; to &quot;very satisfied&quot; with the current treatment (5 categories). Preference compared the current study medication to previous medications, with responses from &quot;much rather prefer my previous medication&quot; to &quot;much rather prefer the medication administered to me during the study&quot; (5 categories). The side effects responses range from &quot;significantly less side effects&quot; to &quot;significantly more side effects&quot; (5 categories). Positive responses for each item were defined as follows: Satisfaction: &quot;Very Satisfied&quot; or &quot;Somewhat Satisfied&quot;; Preference: &quot;Much Prefer Study Medication&quot; or &quot;Prefer Study Medication&quot;; Side Effects: &quot;Much-Less Side Effects&quot; or &quot;Less Side Effects&quot;.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">311</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>120mg/120mg Galcanezumab - Episodic Migraine (EM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 milligram (loading dose) of Galcanezumab at first dosing visit followed by 120 milligram (mg) once a month for a year by subcutaneous (SC) injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>240mg/240mg Galcanezumab - EM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo/ 120mg Galcanezumab - EM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo/ 240mg Galcanezumab - EM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>120mg Galcanezumab - CM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>240mg Galcanezumab - CM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Galcanezumab</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>120mg Galcanezumab - CM</arm_group_label>
    <arm_group_label>120mg/120mg Galcanezumab - Episodic Migraine (EM)</arm_group_label>
    <arm_group_label>240mg Galcanezumab - CM</arm_group_label>
    <arm_group_label>240mg/240mg Galcanezumab - EM</arm_group_label>
    <arm_group_label>Placebo/ 120mg Galcanezumab - EM</arm_group_label>
    <arm_group_label>Placebo/ 240mg Galcanezumab - EM</arm_group_label>
    <other_name>LY2951742</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For Episodic Migraine participants: Participants who completed the treatment period of&#xD;
             Galcanezumab study CGAN.&#xD;
&#xD;
          -  Have a diagnosis of chronic migraine as defined by International Headache Society&#xD;
             (IHS) International Classification of Headache Disorders (ICHD)-3 beta guidelines&#xD;
             (1.3) (ICHD-3 2013), with a history of migraine headaches of at least 1 year prior to&#xD;
             screening, and migraine onset prior to age 50.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  For Chronic Migraine participants:&#xD;
&#xD;
               -  Are currently enrolled in or have participated within the last 30 days or within&#xD;
                  5 half-lives (whichever is longer) in a clinical trial involving an&#xD;
                  investigational product.&#xD;
&#xD;
               -  Current use or prior exposure to Galcanezumab or other antibodies of calcitonin&#xD;
                  gene-related peptide (CGRP) or its receptor.&#xD;
&#xD;
               -  Known hypersensitivity to multiple drugs, monoclonal antibodies or other&#xD;
                  therapeutic proteins, or to Galcanezumab and the excipients in the&#xD;
                  investigational product.&#xD;
&#xD;
               -  History of persistent daily headache, cluster headache or migraine subtypes&#xD;
                  including hemiplegic (sporadic or familial) migraine, ophthalmoplegic migraine,&#xD;
                  and migraine with brainstem aura (basilar-type migraine) defined by IHS ICHD-3&#xD;
                  beta.&#xD;
&#xD;
               -  Failure to respond to 3 or more adequately dosed migraine preventive treatments&#xD;
                  from different classes (that is, maximum tolerated dose for at least 2 months).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Chofu-shi</city>
        <zip>182-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Fukui</city>
        <zip>918 8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Fukuoka</city>
        <zip>816 0824</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Higashiosaka</city>
        <zip>578-8588</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Hiroshima</city>
        <zip>730-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Ibaraki</city>
        <zip>300-1206</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Iruma-Gun</city>
        <zip>350-0495</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.</name>
      <address>
        <city>Kagawa</city>
        <zip>769-0103</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kagoshima</city>
        <zip>892-0842</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kagoshima</city>
        <zip>892-0844</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kai-Shi</city>
        <zip>400-0124</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kanoya-City</city>
        <zip>893-0032</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kasaoka-shi</city>
        <zip>714-0043</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kasuga-shi</city>
        <zip>816-0802</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kobe</city>
        <zip>658-0064</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kochi-Shi</city>
        <zip>780-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kochi</city>
        <zip>780-8011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kyoto</city>
        <zip>600-8811</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Kyoto</city>
        <zip>606-0851</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Minato-Ku</city>
        <zip>108-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Morioka</city>
        <zip>020-0034</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Morioka</city>
        <zip>020-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Narashino-shi</city>
        <zip>275-0026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Nishinomiya</city>
        <zip>663-8014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Nishinomiya</city>
        <zip>663-8204</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Oita</city>
        <zip>870-0831</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Okayama-shi</city>
        <zip>700-8557</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Osaka-Shi</city>
        <zip>556-0015</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Ota-ku</city>
        <zip>145-0063</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Ota-shi</city>
        <zip>373-8585</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Saijo-shi</city>
        <zip>793-0030</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Saitama</city>
        <zip>338-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Sapporo</city>
        <zip>003-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Sapporo</city>
        <zip>060-8570</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Sendai</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Shibuya-ku</city>
        <zip>151-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Shinjuku-ku</city>
        <zip>160-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Shizuoka</city>
        <zip>420-0853</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Tachikawa-shi</city>
        <zip>190-8531</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Tochigi</city>
        <zip>321-0207</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Tochigi</city>
        <zip>321-0293</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Tokyo</city>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.</name>
      <address>
        <city>Yamaguchi</city>
        <zip>754-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.</name>
      <address>
        <city>Ōsaka</city>
        <zip>560-0012</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2016</study_first_posted>
  <results_first_submitted>August 7, 2020</results_first_submitted>
  <results_first_submitted_qc>August 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 24, 2020</results_first_posted>
  <last_update_submitted>September 8, 2020</last_update_submitted>
  <last_update_submitted_qc>September 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prevention</keyword>
  <keyword>prophylaxis</keyword>
  <keyword>headache</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data are available 6 months after the primary publication and approval of the indication studied in the US and european union (EU), whichever is later. Data will be indefinitely available for requesting.</ipd_time_frame>
    <ipd_access_criteria>A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.</ipd_access_criteria>
    <ipd_url>https://vivli.org/</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol: CGAP Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 2, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT02959190/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 16, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT02959190/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol: CGAP (1) Protocol Addendum</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 2, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT02959190/Prot_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Episodic migraine (EM) participants rolled over from parental Study I5Q-JE-CGAN (CGAN - NCT02959177)), and chronic migraine (CM) participants were newly enrolled in this CGAP study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>120 mg Galcanezumab EM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by subcutaneous (SC) injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab or placebo. Participants did not receive any intervention during post-treatment follow-up phase.</description>
        </group>
        <group group_id="P2">
          <title>240 mg Galcanezumab EM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab or placebo. Participants did not receive any intervention during post-treatment follow-up phase.</description>
        </group>
        <group group_id="P3">
          <title>120 mg Galcanezumab CM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled. Participants did not receive any intervention during post-treatment follow-up phase.</description>
        </group>
        <group group_id="P4">
          <title>240 mg Galcanezumab CM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled. Participants did not receive any intervention during post-treatment follow-up phase.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Open Label</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="126"/>
                <participants group_id="P3" count="32"/>
                <participants group_id="P4" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received at Least 1 Dose of Study Drug</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="126"/>
                <participants group_id="P3" count="32"/>
                <participants group_id="P4" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>120mg/120mg Galcanezumab - EM</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>240mg/240mg Galcanezumab - EM</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="62"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Placebo/ 120mg Galcanezumab - EM</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Placebo/ 240mg Galcanezumab - EM</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="64"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="113"/>
                <participants group_id="P2" count="110"/>
                <participants group_id="P3" count="28"/>
                <participants group_id="P4" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Post Treatment Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="117">Participants who discontinued open-label treatment phase had an option to enter post treatment phase</participants>
                <participants group_id="P2" count="120">Participants who discontinued open-label treatment phase had an option to enter post treatment phase</participants>
                <participants group_id="P3" count="32">Participants who discontinued open-label treatment phase had an option to enter post treatment phase</participants>
                <participants group_id="P4" count="32">Participants who discontinued open-label treatment phase had an option to enter post treatment phase</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="114"/>
                <participants group_id="P2" count="119"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants who were randomized and received at least 1 dose of the study drug.</population>
      <group_list>
        <group group_id="B1">
          <title>120mg/120mg Galcanezumab - EM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
        </group>
        <group group_id="B2">
          <title>240mg/240mg Galcanezumab - EM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
        </group>
        <group group_id="B3">
          <title>Placebo/ 120mg Galcanezumab - EM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
        </group>
        <group group_id="B4">
          <title>Placebo/ 240mg Galcanezumab - EM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
        </group>
        <group group_id="B5">
          <title>120mg Galcanezumab - CM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
        </group>
        <group group_id="B6">
          <title>240mg Galcanezumab - CM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
            <count group_id="B2" value="62"/>
            <count group_id="B3" value="62"/>
            <count group_id="B4" value="64"/>
            <count group_id="B5" value="32"/>
            <count group_id="B6" value="33"/>
            <count group_id="B7" value="311"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.95" spread="10.04"/>
                    <measurement group_id="B2" value="45.47" spread="9.79"/>
                    <measurement group_id="B3" value="45.35" spread="10.69"/>
                    <measurement group_id="B4" value="45.08" spread="8.88"/>
                    <measurement group_id="B5" value="41.88" spread="9.40"/>
                    <measurement group_id="B6" value="43.70" spread="11.53"/>
                    <measurement group_id="B7" value="44.71" spread="9.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="58"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="27"/>
                    <measurement group_id="B7" value="268"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="33"/>
                    <measurement group_id="B7" value="311"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="33"/>
                    <measurement group_id="B7" value="311"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="33"/>
                    <measurement group_id="B7" value="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Had Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)</title>
        <description>A TEAE started on or after the date and time of the first dose of study drug administered in this study, or started prior to the study drug administration but worsened after the study drug started. Clinically significant events were defined as SAEs and other non-serious adverse events (AEs). A summary of SAEs and other non-serious AEs is located in the Reported Adverse Events module.</description>
        <time_frame>Up To 16 Months</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab..</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)</title>
          <description>A TEAE started on or after the date and time of the first dose of study drug administered in this study, or started prior to the study drug administration but worsened after the study drug started. Clinically significant events were defined as SAEs and other non-serious adverse events (AEs). A summary of SAEs and other non-serious AEs is located in the Reported Adverse Events module.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="62"/>
                <count group_id="O4" value="64"/>
                <count group_id="O5" value="32"/>
                <count group_id="O6" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="54"/>
                    <measurement group_id="O4" value="61"/>
                    <measurement group_id="O5" value="31"/>
                    <measurement group_id="O6" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pharmacokinetics (PK): Serum Concentration of Galcanezumab</title>
        <description>Serum Concentration of Galcanezumab at month 12 is reported.</description>
        <time_frame>Month 12: Predose</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had evaluable galcanezumab PK data.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Pharmacokinetics (PK): Serum Concentration of Galcanezumab</title>
          <description>Serum Concentration of Galcanezumab at month 12 is reported.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had evaluable galcanezumab PK data.</population>
          <units>nanogram/milliliter (ng/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21100" spread="6120"/>
                    <measurement group_id="O2" value="46000" spread="15300"/>
                    <measurement group_id="O3" value="21000" spread="7290"/>
                    <measurement group_id="O4" value="42200" spread="12400"/>
                    <measurement group_id="O5" value="20100" spread="8550"/>
                    <measurement group_id="O6" value="39600" spread="13600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pharmacodynamics (PD): Plasma Concentration of Total Calcitonin Gene-Related Peptide (CGRP)</title>
        <description>Plasma Concentration of total CGRP at month 12 is reported.</description>
        <time_frame>Month 12: Predose</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had measurable CGRP concentrations.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Pharmacodynamics (PD): Plasma Concentration of Total Calcitonin Gene-Related Peptide (CGRP)</title>
          <description>Plasma Concentration of total CGRP at month 12 is reported.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had measurable CGRP concentrations.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="1.26"/>
                    <measurement group_id="O2" value="5.87" spread="1.45"/>
                    <measurement group_id="O3" value="4.69" spread="1.45"/>
                    <measurement group_id="O4" value="5.59" spread="1.45"/>
                    <measurement group_id="O5" value="4.37" spread="1.40"/>
                    <measurement group_id="O6" value="5.19" spread="1.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Developing Anti-Drug Antibodies (ADA)</title>
        <description>Treatment emergent ADA will be defined as any of the following:&#xD;
A negative baseline result and a positive post-baseline ADA result with a titer ≥20. This is also called treatment-induced ADA.&#xD;
A positive baseline result and a positive post-baseline ADA result with a ≥4-fold increase in titers (for example, baseline titer of 10 increasing to ≥40 post-baseline). This is called treatment-boosted ADA.</description>
        <time_frame>Month 0, 1, 2, 3, 6, 9, 12 and 16: Predose; Month 0 and 14 days Postdose</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had evaluable immunogenicity data.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Developing Anti-Drug Antibodies (ADA)</title>
          <description>Treatment emergent ADA will be defined as any of the following:&#xD;
A negative baseline result and a positive post-baseline ADA result with a titer ≥20. This is also called treatment-induced ADA.&#xD;
A positive baseline result and a positive post-baseline ADA result with a ≥4-fold increase in titers (for example, baseline titer of 10 increasing to ≥40 post-baseline). This is called treatment-boosted ADA.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had evaluable immunogenicity data.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="62"/>
                <count group_id="O4" value="64"/>
                <count group_id="O5" value="32"/>
                <count group_id="O6" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.07"/>
                    <measurement group_id="O2" value="9.68"/>
                    <measurement group_id="O3" value="16.13"/>
                    <measurement group_id="O4" value="10.94"/>
                    <measurement group_id="O5" value="12.50"/>
                    <measurement group_id="O6" value="18.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Baseline in the Number of Migraine Headache Days (MHDs)</title>
        <description>Migraine Headache Day (MHD):A calendar day on which a migraine headache or probable migraine headache occurred.&#xD;
Migraine Headache (EM Participants): A headache, with or without aura, of ≥30 minutes duration with both of the following required features (A and B): A) At least 2 of the following headache characteristics: Unilateral location; Pulsatile quality; Moderate or severe pain intensity; Aggravation by or causing avoidance of routine physical activity; AND B) During headache at least one of the following: Nausea and/or vomiting; Photophobia and phonophobia.&#xD;
Migraine Headache (CM Participants) : A headache, with or without aura, of greater than or equal to (≥30) minutes duration which meets criteria A and B or meets criterion C: A and B criteria as described above and criteria C) The headache is believed by the participant to be migraine at onset and is relieved by a triptan or ergot derivative.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in the Number of Migraine Headache Days (MHDs)</title>
          <description>Migraine Headache Day (MHD):A calendar day on which a migraine headache or probable migraine headache occurred.&#xD;
Migraine Headache (EM Participants): A headache, with or without aura, of ≥30 minutes duration with both of the following required features (A and B): A) At least 2 of the following headache characteristics: Unilateral location; Pulsatile quality; Moderate or severe pain intensity; Aggravation by or causing avoidance of routine physical activity; AND B) During headache at least one of the following: Nausea and/or vomiting; Photophobia and phonophobia.&#xD;
Migraine Headache (CM Participants) : A headache, with or without aura, of greater than or equal to (≥30) minutes duration which meets criteria A and B or meets criterion C: A and B criteria as described above and criteria C) The headache is believed by the participant to be migraine at onset and is relieved by a triptan or ergot derivative.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>MHDs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.82" spread="2.96"/>
                    <measurement group_id="O2" value="-1.49" spread="4.11"/>
                    <measurement group_id="O3" value="-4.29" spread="4.07"/>
                    <measurement group_id="O4" value="-3.23" spread="5.81"/>
                    <measurement group_id="O5" value="-9.44" spread="6.16"/>
                    <measurement group_id="O6" value="-8.97" spread="8.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Baseline in the Number of Headache Days (HDs)</title>
        <description>A headache day is calendar day on which any type of headache occurs,(including migraine headache, probable migraine headache, and non-migraine headache).</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in the Number of Headache Days (HDs)</title>
          <description>A headache day is calendar day on which any type of headache occurs,(including migraine headache, probable migraine headache, and non-migraine headache).</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>Headache days (HDs)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.37" spread="3.62"/>
                    <measurement group_id="O2" value="-1.75" spread="4.57"/>
                    <measurement group_id="O3" value="-5.04" spread="4.71"/>
                    <measurement group_id="O4" value="-4.00" spread="5.14"/>
                    <measurement group_id="O5" value="-9.30" spread="6.83"/>
                    <measurement group_id="O6" value="-9.42" spread="8.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Meeting Criteria for Reductions From Baseline Greater Than or Equal to (≥) 50% in Number of Migraine Headache Days</title>
        <description>Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred. A 50% responder in a particular month is any participant who has a ≥50% reduction from baseline in the monthly number of migraine headache attacks in a 30-day interval.</description>
        <time_frame>Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Meeting Criteria for Reductions From Baseline Greater Than or Equal to (≥) 50% in Number of Migraine Headache Days</title>
          <description>Migraine Headache Day (MHD): A calendar day on which a migraine headache or probable migraine headache occurred. A 50% responder in a particular month is any participant who has a ≥50% reduction from baseline in the monthly number of migraine headache attacks in a 30-day interval.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="46"/>
                <count group_id="O3" value="55"/>
                <count group_id="O4" value="56"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.9"/>
                    <measurement group_id="O2" value="45.7"/>
                    <measurement group_id="O3" value="52.7"/>
                    <measurement group_id="O4" value="46.4"/>
                    <measurement group_id="O5" value="35.7"/>
                    <measurement group_id="O6" value="51.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Baseline in the Number of Monthly Migraine Headache Days Requiring Medication for the Acute Treatment of Migraine Headache</title>
        <description>Migraine Headache Day (MHD) with Acute Medication Use: Calendar days on which migraine or probable migraine occurs, requiring acute medication.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in the Number of Monthly Migraine Headache Days Requiring Medication for the Acute Treatment of Migraine Headache</title>
          <description>Migraine Headache Day (MHD) with Acute Medication Use: Calendar days on which migraine or probable migraine occurs, requiring acute medication.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>MHDs with medication use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.40" spread="2.54"/>
                    <measurement group_id="O2" value="-1.00" spread="3.59"/>
                    <measurement group_id="O3" value="-3.87" spread="3.84"/>
                    <measurement group_id="O4" value="-3.01" spread="5.76"/>
                    <measurement group_id="O5" value="-8.36" spread="6.29"/>
                    <measurement group_id="O6" value="-7.43" spread="7.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Change From Baseline in the Number of Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache</title>
        <description>Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache: Calendar days on which headache, migraine or probable migraine occurs, requiring acute medication.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change From Baseline in the Number of Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache</title>
          <description>Monthly Migraine Headache Days or Headache Days Requiring Medication for the Acute Treatment of Migraine Headache or Headache: Calendar days on which headache, migraine or probable migraine occurs, requiring acute medication.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>MHDs and HDs with medication use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.62" spread="3.21"/>
                    <measurement group_id="O2" value="-1.17" spread="3.89"/>
                    <measurement group_id="O3" value="-4.47" spread="4.81"/>
                    <measurement group_id="O4" value="-3.43" spread="5.53"/>
                    <measurement group_id="O5" value="-8.21" spread="6.84"/>
                    <measurement group_id="O6" value="-7.48" spread="8.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Patient Global Impression of Severity (PGI-S) Score</title>
        <description>The PGI-S scale is a patient-rated instrument that measures patients own global impression of their illness severity. The patient was instructed as follows: &quot;Considering migraine as a chronic condition, how would you rate your level of illness?&quot; Response options were from 1 (&quot;normal, not at all ill&quot;) to 7 (&quot;extremely ill&quot;).</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Patient Global Impression of Severity (PGI-S) Score</title>
          <description>The PGI-S scale is a patient-rated instrument that measures patients own global impression of their illness severity. The patient was instructed as follows: &quot;Considering migraine as a chronic condition, how would you rate your level of illness?&quot; Response options were from 1 (&quot;normal, not at all ill&quot;) to 7 (&quot;extremely ill&quot;).</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.29" spread="0.76"/>
                    <measurement group_id="O2" value="-0.04" spread="0.76"/>
                    <measurement group_id="O3" value="-0.02" spread="0.66"/>
                    <measurement group_id="O4" value="0.11" spread="0.77"/>
                    <measurement group_id="O5" value="-0.07" spread="1.59"/>
                    <measurement group_id="O6" value="-0.81" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline on the Migraine Disability Assessment Test (MIDAS) Total Score</title>
        <description>The MIDAS is a participant-rated scale which was designed to quantify headache-related disability over a 3-month period. This instrument consists of five items that reflect the number of days reported as missing or with reduced productivity at work or home, and the number of days of missed social events. Each item has a numeric response range from 0 to 90 days, if days are missed from work or home they are not counted as days with reduced productivity at work or home. The numeric responses are summed to produce a total score ranging from 0 to 270, in which a higher value is indicative of more disability.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline on the Migraine Disability Assessment Test (MIDAS) Total Score</title>
          <description>The MIDAS is a participant-rated scale which was designed to quantify headache-related disability over a 3-month period. This instrument consists of five items that reflect the number of days reported as missing or with reduced productivity at work or home, and the number of days of missed social events. Each item has a numeric response range from 0 to 90 days, if days are missed from work or home they are not counted as days with reduced productivity at work or home. The numeric responses are summed to produce a total score ranging from 0 to 270, in which a higher value is indicative of more disability.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="8.99"/>
                    <measurement group_id="O2" value="-0.42" spread="15.94"/>
                    <measurement group_id="O3" value="-8.67" spread="17.39"/>
                    <measurement group_id="O4" value="-4.60" spread="12.77"/>
                    <measurement group_id="O5" value="-20.71" spread="32.66"/>
                    <measurement group_id="O6" value="-15.48" spread="32.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline on the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1</title>
        <description>MSQ version 2.1 is a health status instrument,with a 4-week recall period,developed to address physical &amp; emotional limitations of specific concern to individuals with migraine.Addressing the impact of migraine on work or daily activities,relationships with family &amp; friends,leisure time,productivity,concentration, energy,tiredness &amp; feelings.It consists of 14 items addressing 3 domains:(1)Role Function-Restrictive (items 1-7);(2)Role Function- Preventive (items 8-11);&amp;(3)Emotional Function (items 12-14).Response options range from &quot;none of the time&quot; (value 1) to &quot;all of the time&quot; (value 6), &amp; are reverse-recoded (value 6 to 1) before the domain scores are calculated.Total raw scores for each domain is the sum of the final item value for all of the items in that domain.After total raw score is computed for each domain &amp; total score, they are transformed to a 0-100 scale with higher scores indicating a better health status &amp; a positive change in scores reflecting functional improvement.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline on the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1</title>
          <description>MSQ version 2.1 is a health status instrument,with a 4-week recall period,developed to address physical &amp; emotional limitations of specific concern to individuals with migraine.Addressing the impact of migraine on work or daily activities,relationships with family &amp; friends,leisure time,productivity,concentration, energy,tiredness &amp; feelings.It consists of 14 items addressing 3 domains:(1)Role Function-Restrictive (items 1-7);(2)Role Function- Preventive (items 8-11);&amp;(3)Emotional Function (items 12-14).Response options range from &quot;none of the time&quot; (value 1) to &quot;all of the time&quot; (value 6), &amp; are reverse-recoded (value 6 to 1) before the domain scores are calculated.Total raw scores for each domain is the sum of the final item value for all of the items in that domain.After total raw score is computed for each domain &amp; total score, they are transformed to a 0-100 scale with higher scores indicating a better health status &amp; a positive change in scores reflecting functional improvement.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had baseline and at least one post baseline value.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" spread="8.68"/>
                    <measurement group_id="O2" value="0.38" spread="11.97"/>
                    <measurement group_id="O3" value="7.51" spread="10.58"/>
                    <measurement group_id="O4" value="4.56" spread="11.22"/>
                    <measurement group_id="O5" value="19.23" spread="12.57"/>
                    <measurement group_id="O6" value="18.31" spread="15.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Function-Restrictive Domain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.68" spread="9.77"/>
                    <measurement group_id="O2" value="0.22" spread="13.75"/>
                    <measurement group_id="O3" value="8.77" spread="12.74"/>
                    <measurement group_id="O4" value="4.96" spread="12.60"/>
                    <measurement group_id="O5" value="22.65" spread="15.08"/>
                    <measurement group_id="O6" value="22.96" spread="17.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role Function-Preventive Domain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="9.70"/>
                    <measurement group_id="O2" value="0.75" spread="13.17"/>
                    <measurement group_id="O3" value="7.16" spread="10.18"/>
                    <measurement group_id="O4" value="3.77" spread="12.86"/>
                    <measurement group_id="O5" value="15.89" spread="13.68"/>
                    <measurement group_id="O6" value="13.52" spread="16.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotional Function Domain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="10.54"/>
                    <measurement group_id="O2" value="0.25" spread="11.47"/>
                    <measurement group_id="O3" value="5.06" spread="11.47"/>
                    <measurement group_id="O4" value="4.68" spread="12.34"/>
                    <measurement group_id="O5" value="15.71" spread="13.96"/>
                    <measurement group_id="O6" value="13.83" spread="17.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Positive Responses on Patient Satisfaction With Medication Questionnaire-Modified (PSMQ-M)</title>
        <description>The PSMQ-M is a self-rated scale which measures participants level of satisfaction with study medication.The scale has been modified for use in this study, assessing 3 items related to the clinical trial treatment over the past 4 weeks: satisfaction, preference, and side effects.Satisfaction responses range from &quot;very unsatisfied&quot; to &quot;very satisfied&quot; with the current treatment (5 categories). Preference compared the current study medication to previous medications, with responses from &quot;much rather prefer my previous medication&quot; to &quot;much rather prefer the medication administered to me during the study&quot; (5 categories). The side effects responses range from &quot;significantly less side effects&quot; to &quot;significantly more side effects&quot; (5 categories). Positive responses for each item were defined as follows: Satisfaction: &quot;Very Satisfied&quot; or &quot;Somewhat Satisfied&quot;; Preference: &quot;Much Prefer Study Medication&quot; or &quot;Prefer Study Medication&quot;; Side Effects: &quot;Much-Less Side Effects&quot; or &quot;Less Side Effects&quot;.</description>
        <time_frame>Month 12</time_frame>
        <population>All participants who were randomized and received at least 1 dose of the study drug and had month 12 PSMQ-M measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>120mg/120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
          </group>
          <group group_id="O2">
            <title>240mg/240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
          </group>
          <group group_id="O3">
            <title>Placebo/ 120mg Galcanezumab - EM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
          </group>
          <group group_id="O4">
            <title>Placebo/ 240mg Galcanezumab - EM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
          </group>
          <group group_id="O5">
            <title>120mg Galcanezumab - CM</title>
            <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
          </group>
          <group group_id="O6">
            <title>240mg Galcanezumab - CM</title>
            <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Positive Responses on Patient Satisfaction With Medication Questionnaire-Modified (PSMQ-M)</title>
          <description>The PSMQ-M is a self-rated scale which measures participants level of satisfaction with study medication.The scale has been modified for use in this study, assessing 3 items related to the clinical trial treatment over the past 4 weeks: satisfaction, preference, and side effects.Satisfaction responses range from &quot;very unsatisfied&quot; to &quot;very satisfied&quot; with the current treatment (5 categories). Preference compared the current study medication to previous medications, with responses from &quot;much rather prefer my previous medication&quot; to &quot;much rather prefer the medication administered to me during the study&quot; (5 categories). The side effects responses range from &quot;significantly less side effects&quot; to &quot;significantly more side effects&quot; (5 categories). Positive responses for each item were defined as follows: Satisfaction: &quot;Very Satisfied&quot; or &quot;Somewhat Satisfied&quot;; Preference: &quot;Much Prefer Study Medication&quot; or &quot;Prefer Study Medication&quot;; Side Effects: &quot;Much-Less Side Effects&quot; or &quot;Less Side Effects&quot;.</description>
          <population>All participants who were randomized and received at least 1 dose of the study drug and had month 12 PSMQ-M measurement.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="58"/>
                <count group_id="O4" value="57"/>
                <count group_id="O5" value="28"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Responder for satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.4"/>
                    <measurement group_id="O2" value="73.6"/>
                    <measurement group_id="O3" value="72.4"/>
                    <measurement group_id="O4" value="73.7"/>
                    <measurement group_id="O5" value="82.1"/>
                    <measurement group_id="O6" value="74.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responder for preference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.8"/>
                    <measurement group_id="O2" value="73.6"/>
                    <measurement group_id="O3" value="75.9"/>
                    <measurement group_id="O4" value="75.4"/>
                    <measurement group_id="O5" value="85.7"/>
                    <measurement group_id="O6" value="81.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responder for side effect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.6"/>
                    <measurement group_id="O2" value="69.8"/>
                    <measurement group_id="O3" value="72.4"/>
                    <measurement group_id="O4" value="71.9"/>
                    <measurement group_id="O5" value="82.1"/>
                    <measurement group_id="O6" value="81.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up To 16 Months</time_frame>
      <desc>All participants who were randomized and received at least 1 dose of the study drug. Gender specific events only occurring in male or female participants have had the number of participants at risk adjusted accordingly.</desc>
      <group_list>
        <group group_id="E1">
          <title>120mg/120mg Galcanezumab - Open-Label Treatment Phase (Ph) -EM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants (pts) rolled over from CGAN (NCT02959177) 120 mg Galcanezumab.</description>
        </group>
        <group group_id="E2">
          <title>240mg/240mg Galcanezumab - Open-Label Treatment Ph-EM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) 240 mg Galcanezumab.</description>
        </group>
        <group group_id="E3">
          <title>Placebo/ 120mg Galcanezumab - Open-Label Treatment - EM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. EM participants rolled over from CGAN (NCT02959177) placebo.</description>
        </group>
        <group group_id="E4">
          <title>Placebo/ 240mg Galcanezumab - Open-Label Treatment-EM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. EM participants rolled over from CGAN (NCT02959177) Placebo.</description>
        </group>
        <group group_id="E5">
          <title>120mg Galcanezumab - Open-Label Treatment Phase-CM</title>
          <description>240 mg (loading dose) of Galcanezumab at first dosing visit followed by 120 mg once a month for a year by SC injection. Participants with CM were enrolled.</description>
        </group>
        <group group_id="E6">
          <title>240mg Galcanezumab - Open-Label Treatment Phase-CM</title>
          <description>240 mg Galcanezumab given SC once a month for a year. Participants with CM were enrolled.</description>
        </group>
        <group group_id="E7">
          <title>120mg Galcanezumab - Post-Treatment Phase - EM</title>
          <description>Participants didn't received any intervention</description>
        </group>
        <group group_id="E8">
          <title>240mg Galcanezumab - Post-Treatment Phase - EM</title>
          <description>Participants didn't received any intervention</description>
        </group>
        <group group_id="E9">
          <title>120mg Galcanezumab - Post-Treatment Phase - CM</title>
          <description>Participants didn't received any intervention</description>
        </group>
        <group group_id="E10">
          <title>240mg Galcanezumab - Post-Treatment Phase - CM</title>
          <description>Participants didn't received any intervention</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pelvic inflammatory disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="62"/>
                <counts group_id="E3" subjects_affected="54" subjects_at_risk="62"/>
                <counts group_id="E4" subjects_affected="61" subjects_at_risk="64"/>
                <counts group_id="E5" subjects_affected="31" subjects_at_risk="32"/>
                <counts group_id="E6" subjects_affected="29" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="40" subjects_at_risk="117"/>
                <counts group_id="E8" subjects_affected="37" subjects_at_risk="120"/>
                <counts group_id="E9" subjects_affected="10" subjects_at_risk="32"/>
                <counts group_id="E10" subjects_affected="13" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Deafness transitory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Thyroid cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Foreign body sensation in eyes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ocular discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="4" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Angular cheilitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Chapped lips</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="58"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="62"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dental cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia teeth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Lip erosion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Oesophageal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Periodontal disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tooth impacted</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tooth loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hangover</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="5" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" events="37" subjects_affected="11" subjects_at_risk="58"/>
                <counts group_id="E2" events="66" subjects_affected="15" subjects_at_risk="62"/>
                <counts group_id="E3" events="53" subjects_affected="11" subjects_at_risk="62"/>
                <counts group_id="E4" events="50" subjects_affected="16" subjects_at_risk="64"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E6" events="15" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="58"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="6" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="10" subjects_affected="7" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="7" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="7" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="62"/>
                <counts group_id="E4" events="31" subjects_affected="11" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="6" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" events="26" subjects_affected="7" subjects_at_risk="58"/>
                <counts group_id="E2" events="22" subjects_affected="9" subjects_at_risk="62"/>
                <counts group_id="E3" events="33" subjects_affected="10" subjects_at_risk="62"/>
                <counts group_id="E4" events="68" subjects_affected="17" subjects_at_risk="64"/>
                <counts group_id="E5" events="9" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E6" events="18" subjects_affected="4" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="13" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="5" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" events="17" subjects_affected="6" subjects_at_risk="58"/>
                <counts group_id="E2" events="12" subjects_affected="5" subjects_at_risk="62"/>
                <counts group_id="E3" events="12" subjects_affected="4" subjects_at_risk="62"/>
                <counts group_id="E4" events="17" subjects_affected="7" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injection site warmth</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injury associated with device</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallbladder polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Sarcoidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Adenoviral conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Adenovirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="6" subjects_affected="4" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="5" subjects_affected="4" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cystitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dermatophytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="58"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Genital herpes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Herpes dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="58"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="62"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="62"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="64"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="44" subjects_affected="27" subjects_at_risk="58"/>
                <counts group_id="E2" events="45" subjects_affected="29" subjects_at_risk="62"/>
                <counts group_id="E3" events="44" subjects_affected="25" subjects_at_risk="62"/>
                <counts group_id="E4" events="48" subjects_affected="32" subjects_at_risk="64"/>
                <counts group_id="E5" events="19" subjects_affected="13" subjects_at_risk="32"/>
                <counts group_id="E6" events="23" subjects_affected="16" subjects_at_risk="33"/>
                <counts group_id="E7" events="10" subjects_affected="9" subjects_at_risk="117"/>
                <counts group_id="E8" events="8" subjects_affected="8" subjects_at_risk="120"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pelvic inflammatory disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pulpitis dental</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Viral tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Avulsion fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Comminuted fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Heat illness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Heat stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Spinal column injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tooth injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Anti-cyclic citrullinated peptide antibody positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Blood uric acid increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Platelet count increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Urine ketone body present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Myofascial pain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Nodal osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Temporomandibular joint syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Head discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Occipital neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Taste disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Thunderclap headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Frustration tolerance decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Middle insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hypertonic bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Adenomyosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="96"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Menopausal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Menopausal symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Choking sensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Asteatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cold urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Dyshidrotic eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Eczema asteatotic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Eczema nummular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Erythema annulare</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hand dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Miliaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Nail bed bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Onychalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Onychomadesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Seborrhoeic dermatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="62"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Urticaria chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Urticaria thermal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Appendicectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Bone graft</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Cervical polypectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Endodontic procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Haemorrhoid operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Intervertebral disc operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Ligament operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Lipectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Mastectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Polypectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Removal of foreign body</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Sinus operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Skin cyst excision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tendon sheath incision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Wisdom teeth removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="58"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="62"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="64"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="117"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The sponsor can review the study result with PIs prior to public release and can embargo a communication about it until the public release by the contract with Investigator sites.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chief Medical Officer</name_or_title>
      <organization>Eli Lilly and Company</organization>
      <phone>800-545-5979</phone>
      <email>ClinicalTrials.gov@lilly.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

